Nov 02, 2016 20:01 pm UTC| Business
LEESBURG, Va., Nov. 02, 2016 -- K2M Group Holdings, Inc. (Nasdaq:KTWO) (the "Company" or "K2M"), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex...
AxoGen, Inc. Reports Financial Results for Third Quarter 2016
Nov 02, 2016 20:01 pm UTC| Business
ALACHUA, Fla., Nov. 02, 2016 -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced financial results for the third quarter ended September 30,...
Planet Payment Announces Third Quarter 2016 Results
Nov 02, 2016 20:01 pm UTC| Business
LONG BEACH, N.Y., Nov. 02, 2016 -- Planet Payment,Inc. (NASDAQ:PLPM), a provider of international payment and transaction processing and multi-currency processing services, today announced its results for the third...
Immunomedics Announces First Quarter Fiscal 2017 Results and Clinical Program Developments
Nov 02, 2016 20:01 pm UTC| Business
MORRIS PLAINS, N.J., Nov. 02, 2016 -- Immunomedics, Inc. (Nasdaq:IMMU) today reported financial results for the first quarter ended September 30, 2016. The Company also highlighted recent key developments and planned...
Endocyte Announces Third Quarter 2016 Earnings Conference Call
Nov 02, 2016 20:01 pm UTC| Business
WEST LAFAYETTE, Ind., Nov. 02, 2016 -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Wednesday, Nov. 9th, at 4:30 p.m. EST to discuss its third quarter financial results...
Nov 02, 2016 20:01 pm UTC| Business
TUCSON, Ariz., Nov. 02, 2016 -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that its management will be presenting at the...
MacroGenics Provides Update on Corporate Progress and Third Quarter 2016 Financial Results
Nov 02, 2016 20:01 pm UTC| Business
Continued expansion and advancement of product candidatesPortfolio update planned for upcoming RD Day on December 13, 2016 ROCKVILLE, Md., Nov. 02, 2016 -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage...